InvestorsHub Logo

ash111

10/29/18 1:07 PM

#1915 RE: peterus #1914

You welcome. it's newest FDA approval product Zolpimist ( $1.8B Market Potential. About the same Market potential relating other Drug too) just been added ( in the Market) 2 months ago hence will be represented upcoming earnings and beyond.

A strong Pipeline/ Catalysts: (Estimation: December 1, 2018, April 2019). More Catalysts relating other products too.

A possible Buy-out/ Takeover due tiny market cap/float/market space.